Table 2.
TDC | Current Top 1 | XGBoost | |||
---|---|---|---|---|---|
Task | Metric | Method | Score | Score | Rank |
Absorption | |||||
Caco2 | MAE | RDKit2D + MLP | 0.393 ± 0.024 | 0.288 ± 0.011 | 1st |
HIA | AUROC | AttrMasking | 0.978 ± 0.006 | 0.987 ± 0.002 | 1st |
Pgp | AUROC | AttrMasking | 0.929 ± 0.006 | 0.911 ± 0.002 | 4th |
Bioav | AUROC | RDKit2D + MLP | 0.672 ± 0.021 | 0.700 ± 0.010 | 1st |
Lipo | MAE | ContextPred | 0.535 ± 0.012 | 0.533 ± 0.005 | 1st |
AqSol | MAE | AttentiveFP | 0.776 ± 0.008 | 0.727 ± 0.004 | 1st |
Distribution | |||||
BBB | AUROC | ContextPred | 0.897 ± 0.004 | 0.905 ± 0.001 | 1st |
PPBR | MAE | NeuralFP | 9.292 ± 0.384 | 8.251 ± 0.115 | 1st |
VDss | Spearman | RDKit2D + MLP | 0.561 ± 0.025 | 0.612 ± 0.018 | 1st |
Metabolism | |||||
CYP2C9 Inhibition | AUPRC | AttentiveFP | 0.749 ± 0.004 | 0.794 ± 0.004 | 1st |
CYP2D6 Inhibition | AUPRC | AttentiveFP | 0.646 ± 0.014 | 0.721 ± 0.003 | 1st |
CYP3A4 Inhibition | AUPRC | AttentiveFP | 0.851 ± 0.006 | 0.877 ± 0.002 | 1st |
CYP2C9 Substrate | AUPRC | Morgan + MLP | 0.380 ± 0.015 | 0.387 ± 0.018 | 1st |
CYP2D6 Substrate | AUPRC | RDKit2D + MLP | 0.677 ± 0.047 | 0.648 ± 0.023 | 3rd |
CYP3A4 Substrate | AUPRC | CNN | 0.662 ± 0.031 | 0.680 ± 0.005 | 1st |
Excretion | |||||
Half Life | Spearman | Morgan + MLP | 0.329 ± 0.083 | 0.396 ± 0.027 | 1st |
CL-Hepa | Spearman | ContextPred | 0.439 ± 0.026 | 0.420 ± 0.011 | 2nd |
CL-Micro | Spearman | RDKit2D + MLP | 0.586 ± 0.014 | 0.587 ± 0.006 | 1st |
Toxicity | |||||
LD50 | MAE | Morgan + MLP | 0.649 ± 0.019 | 0.602 ± 0.006 | 1st |
hERG | AUROC | RDKit2D + MLP | 0.841 ± 0.020 | 0.806 ± 0.005 | 3rd |
Ames | AUROC | AttrMasking | 0.842 ± 0.008 | 0.859 ± 0.002 | 1st |
DILI | AUROC | AttrMasking | 0.919 ± 0.008 | 0.933 ± 0.011 | 1st |
Only models that have been evaluated by most of the tasks are considered.